Bioindustry Park Silvano Fumero Italy

Bioindustry Park “Silvano Fumero” is an Italian scientific and technological park, specialized in Life Sciences, located in the Piedmont region, near Turin. Bioindustry Park promotes and develops Life Sciences research and innovation by hosting and supporting companies, start-ups and research institutions. Bioindustry Park offers a full range of services aimed at the creation and development of life sciences and health care start-up and spin-off companies not only by providing laboratories and facilities, but also through valuable scientific and business support services. Bioindustry Park “Silvano Fumero” is also the managing company of bioPmed (http://www.biopmed.eu), the Piedmont health care innovation cluster that involves private and public actors in the pharmaceutical, biotech, medtech and eHealth sectors. BioPmed gathers about 100 companies, touching the whole value chain: from research and academic institutions and foundations, to start-ups, SMEs, private and public hospitals and health care centers.
Company Size (Fulltime employees)
Year of foundation
1998
Please specify your partnering goal
Meet companies and investors in order to start new partnerships and activities (scouting and due diligences for investors, EU projects, international cooperation, licensing-out and promotion of our startups)
Headquartner in China
Biotech/Pharma Category
Dr. Arianna Floris
Life sciences Innovation Manager 
Functionality

NeuroZone Italy

Neuro-Zone, since 13 years, supports drug discovery, drug repurposing and research projects in the fields of inflammation and age-related pathologies.
In particular, we have developed pathology-specific platforms to generate rapid and informative data on efficacy, toxicity, metabolism and mechanism of action, supported by proprietary technologies such as MicroTISSUE (dissecting microenvironment-cell interaction in complex inflammatory scenarios) or MITOS (a comprehensive analytical platform for quantitative analysis of mitochondrial function ).
Our approach enables effective selection and ranking of the most promising candidates per indication.
Moreover, we profile candidates at different level of complexity starting from:
a) pharmacology profiling (GPCR; Ion Channel receptors)
b) identification of biochemical pathways responsible for therapeutic efficacy (transcriptomics)
c) disease modified barrier permeability (BBB and endothelial)

Company Size (Fulltime employees)
Year of foundation
2007
Please specify your partnering goal
Commercial partnership in China(representative office in Shanghai expected to open January 2021)
Headquartner in China
Fabio Bianco
President 
Functionality

New.Fa.Dem. Srl Italy

New.Fa.Dem. searches the new partners worldwide for the distribution of its own products.
New.Fa.Dem, a manufacturing company based in Italy and is authorized by Italian Agency of Drugs.
Conducts activities like R&D, Manufacturing, Distribution of ethical drugs, medical devices and cosmetics with own brand or private labeling.
Manufacturing of Creams, Gels, liquid, powder and suppositories.
Three important certifications:
• ISO 9001: 2015 for compliance with international quality management standards;
• ISO 13485: 2016 for congruence with the legislation relating to the quality of medical devices;
• GMP COMPLIANCE for the possession of authorizations and licenses for the production of pharmaceutical products.
Possibility of manufacturing medical devices and cosmetics of the same form in the facility in the near future.
Successfully present in Europe, Middle East and North Africa.
ISO Certifications for compliance of international standards of Quality Management and rules on the quality of Medical Devices.
Website:
www.newfadem.it
Company Size (Fulltime employees)
Year of foundation
1971
Please specify your partnering goal
Looking forward for entering into emerging markets either through Distribution agreements or Private Labeling agreements.
Headquartner in China
Biotech/Pharma Category
Assets Information 1
Lidocaine + Nifedipine|rectal cream|anal fissueres and haemorrhoids|Worldwide
Assets Information 2
Diclofenac|oral drops|pain relief|Worldwide
Biotech/Pharma Asset Stage
Maria Goncharova
BD Director 
Functionality

Panakes Partners SGRSpa Italy

Panakes Partners is a Venture Capital investor financing early and late stage medical companies, with innovative products and great ambition teams.
Panakes invests in seed to pre-IPO rounds mainly in European companies but also in Israel and in the US.
The team provides more than capital working together with entrepreneurs to develop successful businesses as an active and well-connected investor. Panakes has a strong relationships with selected industrial partners of the sector to help companies to accelerate their development
Website:
www.panakes.it
Company Size (Fulltime employees)
Year of foundation
2015
Please specify your partnering goal
to see companies
Headquartner in China
Medtech Category
Mrs. Diana Saraceni
Partner